Total Payments
$143,454
2024 Payments
$29,315
Companies
17
Transactions
188
Medicare Patients
841
Medicare Billing
$128,397
Payment Breakdown by Category
Other$98,163 (68.4%)
Consulting$33,390 (23.3%)
Food & Beverage$5,971 (4.2%)
Travel$5,815 (4.1%)
Education$115.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $90,563 | 30 | 63.1% |
| Consulting Fee | $33,390 | 11 | 23.3% |
| Honoraria | $7,600 | 2 | 5.3% |
| Food and Beverage | $5,971 | 116 | 4.2% |
| Travel and Lodging | $5,815 | 22 | 4.1% |
| Education | $115.52 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $56,928 | 57 | $0 (2023) |
| EMD Serono, Inc. | $32,897 | 23 | $0 (2024) |
| GENZYME CORPORATION | $19,489 | 24 | $0 (2024) |
| Genentech USA, Inc. | $14,258 | 16 | $0 (2024) |
| Horizon Therapeutics plc | $9,089 | 13 | $0 (2023) |
| Amgen Inc. | $7,946 | 10 | $0 (2024) |
| Celgene Corporation | $1,514 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $415.43 | 10 | $0 (2024) |
| ABBVIE INC. | $219.81 | 12 | $0 (2024) |
| TG Therapeutics, Inc. | $205.32 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,315 | 42 | EMD Serono, Inc. ($18,236) |
| 2023 | $26,710 | 26 | EMD Serono, Inc. ($13,269) |
| 2022 | $33,775 | 36 | Biogen, Inc. ($17,050) |
| 2021 | $24,357 | 19 | Biogen, Inc. ($22,241) |
| 2020 | $2,748 | 10 | Celgene Corporation ($1,482) |
| 2019 | $35.42 | 2 | Genentech USA, Inc. ($21.10) |
| 2018 | $17,705 | 25 | Biogen, Inc. ($17,496) |
| 2017 | $8,809 | 28 | GENZYME CORPORATION ($8,449) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 3 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2023 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $128.04 | General |
| 09/29/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $184.99 | General |
| 09/25/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Neurology | ||||||
| 08/17/2023 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,392.00 | General |
| 08/17/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $87.75 | General |
| 08/11/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $74.66 | General |
| 05/20/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $218.22 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $6,900.00 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $353.81 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $312.52 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $143.88 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $108.59 | General |
| Category: Immunology | ||||||
| 05/19/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Immunology | ||||||
| 04/25/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $147.27 | General |
| Category: UPLIZNA | ||||||
| 04/25/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $94.67 | General |
| Category: UPLIZNA | ||||||
| 02/11/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $332.80 | General |
| 12/29/2022 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,507.00 | General |
| Category: Neurology | ||||||
| 12/29/2022 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: Neurology | ||||||
| 12/28/2022 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $97.60 | General |
| Category: Neurology | ||||||
| 12/01/2022 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,507.00 | General |
| Category: Neurology | ||||||
| 11/18/2022 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,212.00 | General |
| 11/11/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| 10/13/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 201 | 256 | $45,637 | $19,610 |
| 2022 | 4 | 215 | 289 | $71,914 | $29,014 |
| 2021 | 3 | 185 | 239 | $58,615 | $24,500 |
| 2020 | 7 | 240 | 5,440 | $162,959 | $55,274 |
Total Patients
841
Total Services
6,224
Medicare Billing
$128,397
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 111 | $28,446 | $11,952 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 44 | $8,484 | $3,545 | 41.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $5,930 | $2,873 | 48.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 34 | 47 | $2,529 | $1,070 | 42.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 23 | $92.00 | $86.24 | 93.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 12 | $156.00 | $83.71 | 53.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 112 | 155 | $44,795 | $18,828 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 68 | $14,076 | $5,486 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $9,775 | $3,654 | 37.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 24 | 43 | $3,268 | $1,046 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 143 | $29,027 | $12,423 | 42.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 79 | $22,363 | $9,162 | 41.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,225 | $2,915 | 40.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 11 | 5,112 | $76,680 | $24,147 | 31.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 110 | 186 | $37,200 | $14,636 | 39.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 55 | $15,400 | $5,121 | 33.3% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 11 | 28 | $10,360 | $3,462 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 21 | $10,689 | $3,402 | 31.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 22 | 22 | $9,350 | $3,173 | 33.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 16 | $3,280 | $1,333 | 40.6% |
About Dr. Rola Mahmoud, MD
Dr. Rola Mahmoud, MD is a Neurology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1114207370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rola Mahmoud, MD has received a total of $143,454 in payments from pharmaceutical and medical device companies, with $29,315 received in 2024. These payments were reported across 188 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($90,563).
As a Medicare-enrolled provider, Mahmoud has provided services to 841 Medicare beneficiaries, totaling 6,224 services with total Medicare billing of $128,397. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Kansas City, MO
- Active Since 08/19/2011
- Last Updated 06/12/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1114207370
Products in Payments
- TYSABRI (Biological) $25,140
- Mavenclad (Drug) $18,754
- VUMERITY (Drug) $14,815
- UPLIZNA (Drug) $9,089
- AUBAGIO (Drug) $8,448
- Ocrevus (Biological) $8,119
- UPLIZNA (Biological) $7,946
- TECFIDERA (Drug) $7,524
- OCREVUS (Biological) $6,138
- ZEPOSIA (Drug) $1,543
- GILENYA (Drug) $304.04
- LEMTRADA (Biological) $236.28
- BOTOX (Biological) $216.92
- BRIUMVI (Drug) $125.00
- Ponvory (Drug) $118.66
- KESIMPTA (Drug) $111.39
- UBRELVY (Drug) $84.96
- Qutenza (Drug) $79.10
- BOTOX CHRONIC MIGRAINE (Drug) $44.76
- LYVISPAH (Drug) $29.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Kansas City
Ivan Osorio, M.d, M.D
Neurology — Payments: $104.6M
Neurology $104.6M
Rajesh Pahwa, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Stanley Fisher, M.d, M.D
Neurology — Payments: $428,656
Neurology $428,656
Richard Dubinsky, M.d, M.D
Neurology — Payments: $168,037
Neurology $168,037
Samuel Goldlust, Md, MD
Neurology — Payments: $140,003
Neurology $140,003
Robert Reddig, Md, MD
Neurology — Payments: $118,074
Neurology $118,074